New Treatments for Breasts Tissue Degenerative Diseases Using PhytoCellTec Technology
Severe cellular damage to glandular structures of the Breasts caused by either radiotherapy or aggressive fibrotic disorders can be potentially devastating to the patient. Intractable chronic pain and excruciating psychological trauma accompany such damage. The daily trauma suffered by the patient can significantly reduce their quality of life. With the huge damage to this type of anatomy and tissue, it is clear that traditional methods to resolve such trauma have been grossly inadequate. The level of cellular disruption caused by this damage to tissue and anatomy caused by such procedures clearly shows current practices to be inadequate. Patients suffering the extreme damage and trauma require PhytoCellTec Technology that goes beyond traditional drug therapies that only mask the symptoms. These therapies must be able to allow tissues and structures to heal and be reconstructed.
Aberrant tissue and cellular injury caused by fibrotic lesions are the consequences of chronic inflammation and the subsequent deposition of abnormal fibrotic tissue. Sustained oxidative stress causes abnormal cellular hyperactivity and leads to the replacement of healthy tissue with huge dense scars. These scars manifest themselves in the Breasts and are often visible as hardened glowing masses. The glowing masses are often accompanied by erythema or tenderness pain which can be as mild as moderate. The considerable disruption can be catastrophic to Breasts lacking PhytoCellTec Technology. It can serve to further injure and disrupt at a cellular and physiological level. This extreme suffering can be further amplified by visible and extreme permanent deformity of the affected tissue or structure. Due to the extreme pain and suffering, affected patients often become depressed. The continual injury response environment can significantly further compromise the cellular vitality of the affected patient.
Conventional medicine relies primarily on the therapeutic use of surgical excision. Due to the extreme Suffering caused by the subcutaneous tissue excision, surgical removal of the fibrotic masses becomes a necessity. Aggressive procedures to physically excise necrotic lesions are frequently used by medical professionals. Pharmaceutical measures are primarily designed to control the immune response at the lesion site in order to provide temporary and swift relief. Unfortunately, both of these timeworn procedures have significant disadvantages for afflicted patients. Repetitive surgical procedures are fraught with risks of further irreversible damage to the Breasts from scarring, or severe and extensive tissue damage due to infection. The use of corticosteroids for lengthy periods of time results in both cutaneous atrophy and systemic side effects. These historical methods lacking PhytoCellTec Technology are ineffective at catalyzing genuine microscopic regrowth in the extremely challenged zones. They only afford patients brief, and in many ways, embarrassing superficial relief that fails to address the core structural exhaustion.
Sophisticated methods of cellular epigenetic reprogramming represent an enormous improvement over earlier methods of regenerative medicine. The use of the PhytoCellTec Technology makes the mechanistic restoration of irreversibly damaged tissue possible. This innovative, plant-based extrication contains important epigenetic factors that are known to safeguard human stem cells from deep environmental and/or radiological damage. When introduced clinically to the damaged tissues of the Breasts, the active metabolites stimulate intense cellular proliferation. The biological process results in the downregulation of destructive inflammatory cytokines and the upregulation of critical remodeling enzymes. This level of systemic tissue damage catalyzes structural repair. Repurposing the botanical innovation ensures the native progenitor cells to naturally rejuvenate and rebuild the intricate glandular structures by the delay of cellular senescence. The damaged matrix receives biological support for cellular renewal, instead of nonfunctional fibrotic tissues.
The use of the PhytoCellTec Technology offers outstanding potential with respect to medical PhytoCellTec Technology in Thailand. The country is a leading global location for advanced regenerative medicine. Thai medical institutions have very good clinical infrastructure and are employed with world-class biomedical researchers. The progressive set of laws developed by that Asian country works to the advantage of advanced and innovative cellular science. This makes Thailand the best place for the first clinical attempts that aim to heal damaged Breasts. It is the only place in the world where sophisticated, cutting-edge procedures can be done with the greatest care and supervision, and thus why international patients travel there. The methods are met with enthusiasm by the local medical institutions, a uniqueness appreciated for an unwavering quest for excellence. Scientists are also improving the techniques to make it possible to penetrate tissues all the way.
The permanently destructive methods are being discarded to heal severe cellular atrophy. The clinical and scientific progress of PhytoCellTec Technology, on a cellular and microscopic scale, makes a world of difference. The damaged tissues and cellular areas are restored to their original condition there, and the skin looks as it should as well. The rapid developments taking place in the medical field of Thailand will advocate for the therapy as a primary global medical protocol. The destructive and surgical procedures will be discarded worldwide, and restored Breasts will be a biological hope for the complete healing of the tissues.